Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Respiratory Infections

References

• Kochanek KD, Murphy SL, Xu J, Tejada-Vera B Deaths: final data for 2014. 2016 Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_04.pdf. Accessed 102, 2017.
   Google Scholar
• Pfuntner A, Wier LM, Stocks C Statistical brief #162: most frequent conditions in U.S. hospitals, 2011. 2013 Available from: https://www.ncbi.nlm.nih.gov/books/NBK169248/pdf/Bookshelf_NBK169248.pdf. Accessed 102, 2017.
   Google Scholar
• Wuerth BA, Bonnewell JP, Wiemken TL, Arnold FW. Trends in pneumonia mortality rates and hospitalizations by organism, United States, 2002-2011(1). Emerg Infect Dis. 2016;22(9):1624–1627. doi:10.3201/eid2209.15068027532154
   PubMed Web of Science ®Google Scholar
• Djordjevic ZM, Folic MM, Jankovic SM. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in intensive care unit. J Infect Public Health. 2017;10(6):740–744. doi:10.1016/j.jiph.2016.11.01628189513
   PubMed Web of Science ®Google Scholar
• Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81–S87. doi:10.1086/65305320597676
   PubMed Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012. Int J Antimicrob Agents. 2014;43(4):328–334. doi:10.1016/j.ijantimicag.2014.01.00724630306
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance global report on surveillance. 2014 Available from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1. Accessed 102, 2017.
   Google Scholar
• Thaden JT, Lewis SS, Hazen KC, et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol. 2014;35(8):978–983. doi:10.1086/67715725026612
   PubMed Web of Science ®Google Scholar
• Cai B, Echols R, Magee G, et al. Prevalence of carbapenem-resistant gram-negative infections in the United States predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis. 2017;4(3):ofx176. doi:10.1093/ofid/ofx17629026867
   PubMedGoogle Scholar
• Muggeo A, Guillard T, Barbe C, et al. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceae in North-Eastern France and outcomes of infected patients. J Antimicrob Chemother. 2017;72(5):1496–1501. doi:10.1093/jac/dkw59028158526
   PubMed Web of Science ®Google Scholar
• Bartsch SM, McKinnell JA, Mueller LE, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48.e49–48.e16. doi:10.1016/j.cmi.2016.09.003
   Web of Science ®Google Scholar
• Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol. 2013;34(6):588–596. doi:10.1086/67062123651889
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Tabak YP, Sievert DM, et al. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol. 2011;32(7):649–655. doi:10.1086/66036021666394
   PubMed Web of Science ®Google Scholar
• Gross AE, Johannes RS, Gupta V, Tabak YP, Srinivasan A, Bleasdale SC. The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 US medical centers. Clin Infect Dis. 2017;65(4):613–618. doi:10.1093/cid/cix37928444166
   PubMed Web of Science ®Google Scholar
• Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301. doi:10.1017/ice.2016.17427573805
   PubMed Web of Science ®Google Scholar
• Agency for Health Care Research and Quality. Clinical Classifications Software (CCS) for ICD-9-CM. 2015 Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed 65, 2019.
   Google Scholar
• Tabak YP, Sun X, Nunez CM, Johannes RS. Using electronic health record data to develop inpatient mortality predictive model: Acute Laboratory Risk of Mortality Score (ALaRMS). J Am Med Inform Assoc. 2014;21(3):455–463. doi:10.1136/amiajnl-2013-00179024097807
   PubMed Web of Science ®Google Scholar
• Corrado RE, Lee D, Lucero DE, Varma JK, Vora NM. Burden of adult community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia: New York City, 2010 to 2014. Chest. 2017;152(5):930–942. doi:10.1016/j.chest.2017.04.16228455128
   PubMed Web of Science ®Google Scholar
• Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–2046. doi:10.1001/jamainternmed.2013.976323999949
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Kilpatrick C, Storr J, et al. Global infection prevention and control priorities 2018-22: a call for action. Lancet Glob Health. 2017;5(12):E1178–E1180. doi:10.1016/S2214-109X(17)30427-8
   Web of Science ®Google Scholar
• Office of Disease Prevention and Health Promotion. National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination. US Department of Health and Human Services; 2013 Available from: https://health.gov/sites/default/files/2019-09/hai-action-plan-executive-summary.pdf. Accessed 611, 2019.
   Google Scholar
• Bahlis LF, Diogo LP, Kuchenbecker RS, Fuchs SC. Clinical, epidemiological, and etiological profile of inpatients with community-acquired pneumonia in a public hospital in the interior of Brazil. J Bras Pneumol. 2018;44(4):261–266. doi:10.1590/s1806-3756201700000043430328925
   PubMed Web of Science ®Google Scholar
• de Miguel-diez J, Lopez-de-Andres A, Hernandez-Barrera V, et al. Decreasing incidence and mortality among hospitalized patients suffering a ventilator-associated pneumonia: analysis of the Spanish national hospital discharge database from 2010 to 2014. Medicine (Baltimore). 2017;96(30):e7625. doi:10.1097/MD.000000000000762528746223
   PubMed Web of Science ®Google Scholar
• Jiang J, Yang J, Jin Y, Cao J, Lu Y. Role of qSOFA in predicting mortality of pneumonia: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(40):e12634. doi:10.1097/MD.000000000001263430290639
   PubMed Web of Science ®Google Scholar
• Talbot GH, Das A, Cush S, et al. Evidence-based study design for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. J Infect Dis. 2019;219(10):1536–1544. doi:10.1093/infdis/jiy57830649434
   PubMed Web of Science ®Google Scholar
• Lye DC, Earnest A, Ling ML, et al. The impact of multidrug resistance in healthcare-associated and nosocomial gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2012;18(5):502–508. doi:10.1111/j.1469-0691.2011.03606.x21851482
   PubMed Web of Science ®Google Scholar
• McCann E, Srinivasan A, DeRyke CA, et al. Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: a multicenter study. Open Forum Infect Dis. 2018;5(10):ofy241. doi:10.1093/ofid/ofy24130364442
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017;17(1):279. doi:10.1186/s12879-017-2383-z28415969
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi:10.1093/cid/ciw353
   Web of Science ®Google Scholar
• Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33(3):250–256. doi:10.1086/66404922314062
   PubMed Web of Science ®Google Scholar
• Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2121. doi:10.1378/chest.122.6.211512475855
   PubMed Web of Science ®Google Scholar
• Hardak E, Avivi I, Berkun L, et al. Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection. 2016;44(4):491–497. doi:10.1007/s15010-016-0873-326792011
   PubMed Web of Science ®Google Scholar
• Nseir S, Di Pompeo C, Soubrier S, et al. Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: a case-control study. Infection. 2004;32(4):210–216. doi:10.1007/s15010-004-3167-015293076
   PubMed Web of Science ®Google Scholar
• Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA. 2012;109(15):5809–5814. doi:10.1073/pnas.112057710922451929
   PubMed Web of Science ®Google Scholar
• Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care. 2005;9(3):R238–R245. doi:10.1186/cc350815987396
   PubMed Web of Science ®Google Scholar